APA (7th ed.) Citation

HW, A., M, G., S, D., M, S., I, S., L, P., . . . S, G. (2021). Effect of age and frailty on the efficacy and tolerability of once-weekly selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma. American journal of hematology, 96(6), 708. https://doi.org/10.1002/ajh.26172

Chicago Style (17th ed.) Citation

HW, Auner, et al. "Effect of Age and Frailty on the Efficacy and Tolerability of Once-weekly Selinexor, Bortezomib, and Dexamethasone in Previously Treated Multiple Myeloma." American Journal of Hematology 96, no. 6 (2021): 708. https://doi.org/10.1002/ajh.26172.

MLA (9th ed.) Citation

HW, Auner, et al. "Effect of Age and Frailty on the Efficacy and Tolerability of Once-weekly Selinexor, Bortezomib, and Dexamethasone in Previously Treated Multiple Myeloma." American Journal of Hematology, vol. 96, no. 6, 2021, p. 708, https://doi.org/10.1002/ajh.26172.